Page results
-
A UCLH patient with a rare hormonal condition is the first in the world to receive a new investigational drug in a first-in-human trial.
-
The service includes diagnosis, quantifying the degree of hearing loss, and rehabilitation of hearing impairment to limit participation restriction.
-
Mr Patrick Grover is a neurosurgeon with a particular expertise in the management of tumours of the skull base such as vestibular schwannomas and meningiomas, as well as Cerebral Aneurysms, AVMs and cavernomas.
-
Mr Pat O'Brien has been a consultant at UCLH since 1999 and specialises in caring for women with medical problems in pregnancy and complicated births. His research interests are in the same areas.
-
As an organisation, UCLH needs to minimise the environmental impact of our buildings and the energy they use and maximise our use of any technology available to support these changes. This page outlines our progress to date.
-
Find & Treat's new prototype Eco-Tricycle will visit parks, hostels, soup kitchens, be able to arrive under bridges or other street outreach locations to screen homeless patients for infectious diseases and more.
-
Mr Laurence Watkins is a consultant neurosurgeon with sub-speciality interests in hydrocephalus, neurovascular surgery, intracranial pressure, chronic headache and neuro-endoscopy
-
This page has been written for patients at Eastman Dental Hospital who are undergoing intravenous sedation.
-
Mr Jonathan Hyam is a consultant neurosurgeon who has an interest in headache, facial pain, movement disorders, and spinal pain.
-
This information is for patients who have attended the emergency department with an undisplaced or minimally displaced fracture (broken bone) at the base of your 5th metatarsal.
File results
-
FOI/2023/0182 - Data privacy compliance tools
-
FOI/2023/0083 - Software systems/ suppliers used at Trust
-
FOI/2023/0069 - Operations waits for under-18s
-
FOI/2023/0073 - Telephony and UC/ collaboration, Microsoft 365 licence and on-premise or cloud storage
-
FOI/2023/0075 - Attrition rates for staff working in advanced practice roles
-
FOI/2023/0080 - Treatment for Myeloid leukaemia (AML) and chronic lymphocytic leukaemia
-
FOI/2023/0081 - Biometric technology wearables/ data collection
-
FOI/2023/0082 - Organisation structure for Performance and Planning department
-
FOI/2023/0099 - Number of autoclaves used at Trust
-
FOI/2023/0103 - Genetic Haemochromatosis patients